Cargando…
A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1
BACKGROUND: Hereditary angioedema (HAE) is a rare, life-threatening disease. The knowledge about the molecular pathogenesis of HAE has derived mainly from investigating blood samples. However, limited data are available on the role of the molecular mechanisms in the affected tissues during HAE attac...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254515/ https://www.ncbi.nlm.nih.gov/pubmed/35787812 http://dx.doi.org/10.1186/s13223-022-00699-7 |
_version_ | 1784740717305790464 |
---|---|
author | Farkas, Henriette Máj, Csilla Kenessey, István Sebestyén, Anna Krencz, Ildikó Pápay, Judit Cervenak, László |
author_facet | Farkas, Henriette Máj, Csilla Kenessey, István Sebestyén, Anna Krencz, Ildikó Pápay, Judit Cervenak, László |
author_sort | Farkas, Henriette |
collection | PubMed |
description | BACKGROUND: Hereditary angioedema (HAE) is a rare, life-threatening disease. The knowledge about the molecular pathogenesis of HAE has derived mainly from investigating blood samples. However, limited data are available on the role of the molecular mechanisms in the affected tissues during HAE attack. OBJECTIVE: The aim of our study was to explore the histological changes occurring in HAE attacks. METHODS: Post mortem macro-, microscopic and immunohistological assessment of upper airway tissues of a patient with HAE due to C1 inhibitor deficiency (C1-INH-HAE) type 2 who died from laryngeal HAE attack was compared with a non-HAE patient who died from other condition without any signs of angioedema. RESULTS: Compared to the control patient, we demonstrated stronger T cell/monocyte infiltration and a more intense C1-INH staining in the C1-INH-HAE patient. The expression of both bradykinin receptors (B1/B2) was observed with a slightly lower level in the C1-INH-HAE patient than in the control patient. PAR1 expression was strongly reduced in the C1-INH-HAE patient suggesting overactivation of this hyperpermeability inducing receptor. CONCLUSION: Our unique case and novel results correspond to the knowledge about C1-INH and BDKRs observed in plasma; however, it revealed new information about the pathomechanism of HAE attack focusing on the potential involvement of PAR1 in edema formation. This observation, if it is verified by subcutaneous biopsy studies, may designate a new therapeutic target in HAE. |
format | Online Article Text |
id | pubmed-9254515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92545152022-07-06 A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1 Farkas, Henriette Máj, Csilla Kenessey, István Sebestyén, Anna Krencz, Ildikó Pápay, Judit Cervenak, László Allergy Asthma Clin Immunol Research BACKGROUND: Hereditary angioedema (HAE) is a rare, life-threatening disease. The knowledge about the molecular pathogenesis of HAE has derived mainly from investigating blood samples. However, limited data are available on the role of the molecular mechanisms in the affected tissues during HAE attack. OBJECTIVE: The aim of our study was to explore the histological changes occurring in HAE attacks. METHODS: Post mortem macro-, microscopic and immunohistological assessment of upper airway tissues of a patient with HAE due to C1 inhibitor deficiency (C1-INH-HAE) type 2 who died from laryngeal HAE attack was compared with a non-HAE patient who died from other condition without any signs of angioedema. RESULTS: Compared to the control patient, we demonstrated stronger T cell/monocyte infiltration and a more intense C1-INH staining in the C1-INH-HAE patient. The expression of both bradykinin receptors (B1/B2) was observed with a slightly lower level in the C1-INH-HAE patient than in the control patient. PAR1 expression was strongly reduced in the C1-INH-HAE patient suggesting overactivation of this hyperpermeability inducing receptor. CONCLUSION: Our unique case and novel results correspond to the knowledge about C1-INH and BDKRs observed in plasma; however, it revealed new information about the pathomechanism of HAE attack focusing on the potential involvement of PAR1 in edema formation. This observation, if it is verified by subcutaneous biopsy studies, may designate a new therapeutic target in HAE. BioMed Central 2022-07-04 /pmc/articles/PMC9254515/ /pubmed/35787812 http://dx.doi.org/10.1186/s13223-022-00699-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Farkas, Henriette Máj, Csilla Kenessey, István Sebestyén, Anna Krencz, Ildikó Pápay, Judit Cervenak, László A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1 |
title | A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1 |
title_full | A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1 |
title_fullStr | A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1 |
title_full_unstemmed | A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1 |
title_short | A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1 |
title_sort | novel pathogenetic factor of laryngeal attack in hereditary angioedema? involvement of protease activated receptor 1 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254515/ https://www.ncbi.nlm.nih.gov/pubmed/35787812 http://dx.doi.org/10.1186/s13223-022-00699-7 |
work_keys_str_mv | AT farkashenriette anovelpathogeneticfactoroflaryngealattackinhereditaryangioedemainvolvementofproteaseactivatedreceptor1 AT majcsilla anovelpathogeneticfactoroflaryngealattackinhereditaryangioedemainvolvementofproteaseactivatedreceptor1 AT kenesseyistvan anovelpathogeneticfactoroflaryngealattackinhereditaryangioedemainvolvementofproteaseactivatedreceptor1 AT sebestyenanna anovelpathogeneticfactoroflaryngealattackinhereditaryangioedemainvolvementofproteaseactivatedreceptor1 AT krenczildiko anovelpathogeneticfactoroflaryngealattackinhereditaryangioedemainvolvementofproteaseactivatedreceptor1 AT papayjudit anovelpathogeneticfactoroflaryngealattackinhereditaryangioedemainvolvementofproteaseactivatedreceptor1 AT cervenaklaszlo anovelpathogeneticfactoroflaryngealattackinhereditaryangioedemainvolvementofproteaseactivatedreceptor1 AT farkashenriette novelpathogeneticfactoroflaryngealattackinhereditaryangioedemainvolvementofproteaseactivatedreceptor1 AT majcsilla novelpathogeneticfactoroflaryngealattackinhereditaryangioedemainvolvementofproteaseactivatedreceptor1 AT kenesseyistvan novelpathogeneticfactoroflaryngealattackinhereditaryangioedemainvolvementofproteaseactivatedreceptor1 AT sebestyenanna novelpathogeneticfactoroflaryngealattackinhereditaryangioedemainvolvementofproteaseactivatedreceptor1 AT krenczildiko novelpathogeneticfactoroflaryngealattackinhereditaryangioedemainvolvementofproteaseactivatedreceptor1 AT papayjudit novelpathogeneticfactoroflaryngealattackinhereditaryangioedemainvolvementofproteaseactivatedreceptor1 AT cervenaklaszlo novelpathogeneticfactoroflaryngealattackinhereditaryangioedemainvolvementofproteaseactivatedreceptor1 |